Efficacy and Safety of Tocilizumab in the Management of Non-Infectious Uveitis Failed with Conventional Immunomodulatory and Anti-TNFα Therapies.
Sign Up to like & getrecommendations! Published in 2022 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2022.2126374
Abstract: PURPOSE To determine the outcomes of intravenous (IV) tocilizumab (TCZ) in patients with non-infectious uveitis who failed with conventional immunomodulatory and anti-TNFα therapies. METHODS Records of seven patients with non-infectious uveitis treated with monthly IV… read more here.
Keywords: non infectious; uveitis failed; conventional immunomodulatory; infectious uveitis ... See more keywords